Drawing on the results showing that the higher MSI proportion and E-Cadherin downregulation were particularly enriched in group IV*, we explored whether there was an association between the CMS and colon cancer risk subgroups stratified by IDO1 and CD8A expression using the TCGA data. This evidence concerns the gene CD8A and colonic neoplasm.